| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,663 |
3,507 |
$652K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,794 |
3,562 |
$641K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,390 |
2,265 |
$384K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
750 |
726 |
$219K |
| 70450 |
Computed tomography, head or brain; without contrast material |
643 |
620 |
$197K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
706 |
675 |
$148K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
768 |
756 |
$137K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,675 |
2,487 |
$134K |
| 80053 |
Comprehensive metabolic panel |
5,015 |
4,586 |
$125K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,181 |
1,151 |
$80K |
| 86901 |
|
1,379 |
1,350 |
$44K |
| 86850 |
|
1,381 |
1,353 |
$43K |
| 36415 |
Collection of venous blood by venipuncture |
6,552 |
5,844 |
$43K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,121 |
1,028 |
$41K |
| 86900 |
|
1,381 |
1,352 |
$31K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,713 |
1,584 |
$27K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,089 |
996 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
527 |
455 |
$25K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
85 |
85 |
$24K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,827 |
2,617 |
$13K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
29 |
29 |
$9K |
| 36000 |
|
132 |
128 |
$5K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
643 |
621 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
190 |
188 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,610 |
3,378 |
$3K |
| J3490 |
Unclassified drugs |
924 |
847 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,322 |
1,248 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
150 |
130 |
$3K |
| 83880 |
|
77 |
75 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,995 |
5,474 |
$2K |
| 81025 |
|
474 |
465 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,686 |
1,532 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
865 |
859 |
$1K |
| 85730 |
|
1,809 |
1,750 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,874 |
2,635 |
$1K |
| 87631 |
|
13 |
13 |
$855.01 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
66 |
65 |
$838.68 |
| 71045 |
Radiologic examination, chest; single view |
1,374 |
1,335 |
$649.19 |
| 85610 |
|
1,785 |
1,727 |
$544.97 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
38 |
37 |
$494.32 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
151 |
141 |
$466.99 |
| 81001 |
|
2,206 |
2,131 |
$446.03 |
| 82962 |
|
438 |
303 |
$412.48 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,627 |
1,498 |
$396.49 |
| 81003 |
|
714 |
701 |
$377.47 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
246 |
238 |
$349.61 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
247 |
246 |
$338.46 |
| J2704 |
Injection, propofol, 10 mg |
103 |
102 |
$309.54 |
| 85027 |
|
72 |
66 |
$295.92 |
| 0225U |
|
504 |
495 |
$292.52 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,648 |
1,578 |
$263.87 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,008 |
988 |
$174.58 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
15 |
12 |
$142.63 |
| 84702 |
|
1,196 |
1,122 |
$114.29 |
| 83735 |
|
789 |
730 |
$113.33 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
67 |
67 |
$106.81 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
55 |
51 |
$61.77 |
| 83690 |
|
1,672 |
1,553 |
$50.14 |
| 84484 |
|
1,536 |
1,405 |
$43.44 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
12 |
12 |
$41.75 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
29 |
29 |
$26.40 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$15.80 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
15 |
12 |
$7.61 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
37 |
37 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |
| 83605 |
|
230 |
216 |
$0.00 |
| 85379 |
|
198 |
196 |
$0.00 |
| 87040 |
|
53 |
52 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
26 |
25 |
$0.00 |